<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05089110</url>
  </required_header>
  <id_info>
    <org_study_id>Immunity cells in COVID-19</org_study_id>
    <nct_id>NCT05089110</nct_id>
  </id_info>
  <brief_title>Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients</brief_title>
  <official_title>Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the expression of TLR 3, 7, and 9 in the population of&#xD;
      peripheral blood mononuclear cells (PBMC) and in B lymphocytes (CD19+), T lymphocytes (CD4+&#xD;
      and CD8+) using flow cytometry in relation to the clinical parameters and outcome of COVID 19&#xD;
      patients .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abnormal stimulation of innate immunity may have a great influence on the immunopathogenesis&#xD;
      of COVID 19 disease .The involvement of innate immunity receptors-toll-like receptors&#xD;
      (TLR)-in the pathogenesis of COVID 19 is not adequately studied. The activation of these&#xD;
      receptors by specific ligands is thought to initiate autoimmune processes[1]. TLR stimulation&#xD;
      leads to increased expression of proinflammatory cytokines (IL-6, IFN&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cytokines storm occurrence in COVID-19 patients</measure>
    <time_frame>Baseline</time_frame>
    <description>To assess whether the expression of toll-like receptors 3,7 and 9 in peripheral blood mononuclear cells related to the clinical status of COVID-19 patients and probability of cytokines storm occurrence</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>COVID-19 Respiratory Infection</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>5 cm blood sample from COVID-19 patients</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed as confirmed COVID-19 when they have a positive result of RT-PCR for&#xD;
        SARS-CoV-2 RNA or confirmed diagnosis by typical clinical picture and radiological methods&#xD;
        , according to the WHO and Egyptian Ministry of Health and Population (MOH) definitions, at&#xD;
        Assiut University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients â‰¥18 years old of both genders.&#xD;
&#xD;
          -  Patients diagnosed as confirmed COVID-19 when they have a positive result of RT-PCR&#xD;
             for SARS-CoV-2 RNA or confirmed diagnosis by typical clinical picture and radiological&#xD;
             methods , according to the WHO and Egyptian Ministry of Health and Population (MOH)&#xD;
             definitions, at Assiut University Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children less than 18 years.&#xD;
&#xD;
          -  Patients refusal to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gamal Agamy, professor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad Adam, professor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fady Markos, resident doctor</last_name>
    <phone>01203456886</phone>
    <email>fadyfedo3296@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Manal AL Khawaga, lecturer</last_name>
    <phone>01009493236</phone>
    <email>Manal_elkhawaga@yahoo.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Matthay MA, Zemans RL, Zimmerman GA, Arabi YM, Beitler JR, Mercat A, Herridge M, Randolph AG, Calfee CS. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019 Mar 14;5(1):18. doi: 10.1038/s41572-019-0069-0. Review.</citation>
    <PMID>30872586</PMID>
  </reference>
  <reference>
    <citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.</citation>
    <PMID>32192578</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 21, 2021</study_first_submitted>
  <study_first_submitted_qc>October 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Fady Khalifa Musa Markos</investigator_full_name>
    <investigator_title>Resident doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

